---

---

tags : Results    symbols : GSK   

save search

---

23andMe Reports Third Quarter Fiscal 2024 Financial Results
Published: 2024-02-07 (Crawled : 21:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -5.4% | O: -0.48% H: 0.16% C: 0.0%
financial results

---

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-13 (Crawled : 22:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 14.85% | O: 0.12% H: 0.14% C: -0.49%
SCYX | $1.44 2.49% 2.43% 130K |

Health Technology

| -16.03% | O: 0.29% H: 4.94% C: -0.58%
update financial results

---

23andMe Reports Second Quarter Fiscal 2024 Financial Results
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 13.38% | O: 0.0% H: 0.03% C: -1.71%
financial results

---

Arrowhead Pharmaceuticals Reports Fiscal 2023 Third Quarter Results
Published: 2023-08-07 (Crawled : 21:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -12.95% | O: 0.62% H: 0.62% C: 0.42%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 15.62% | O: 0.35% H: 0.41% C: 0.41%
ARWR | $22.33 -1.24% -1.25% 960K |

Health Technology

| -29.45% | O: 0.0% H: 0.44% C: -2.65%
pharmaceuticals results

---

Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
Published: 2023-05-10 (Crawled : 11:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 9.78% | O: -1.66% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 9.05% | O: -0.03% H: 0.38% C: 0.25%
ZNTL | $12.97 3.43% 3.32% 1M |

Health Technology

| -43.18% | O: 2.59% H: 4.49% C: 4.23%
pharmaceuticals financial results

---

PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 14.64% | O: 2.04% H: 0.0% C: -3.67%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -40.3% | O: -1.26% H: 2.97% C: 2.7%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 13.18% | O: 0.85% H: 0.31% C: -0.45%
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M |

Health Technology

| 109.85% | O: -0.48% H: 4.49% C: 3.24%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -38.21% | O: -1.74% H: 4.84% C: 3.88%
BEAM | $23.9 -1.69% -1.72% 4.5M |

Health Technology

| -43.23% | O: 0.21% H: 4.84% C: 2.99%
financial results

---

Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HLN | $8.22 1.11% 0.0% 3.6M |

n/a

| 34.31% | O: 0.16% H: 1.79% C: 0.16%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 20.89% | O: -1.68% H: 0.0% C: -0.27%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 12.16% | O: 7.74% H: 0.17% C: 0.17%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -44.15% | O: 3.11% H: 0.88% C: 0.02%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 19.84% | O: 1.72% H: 0.39% C: -0.83%
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M |

Health Technology

| 135.3% | O: 1.81% H: 3.08% C: -0.65%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 7.42% | O: 0.23% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -36.93% | O: 4.54% H: 4.25% C: 0.13%
BEAM | $23.9 -1.69% -1.72% 4.5M |

Health Technology

| -45.76% | O: 3.25% H: 1.41% C: -2.48%
ARVN | $34.78 1.43% 1.41% 940K |

Health Technology

| -30.15% | O: 1.49% H: 3.25% C: 1.68%
results

---

Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 6.09% | O: -12.81% H: 8.43% C: 5.21%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 3.79% | O: -8.67% H: 2.89% C: 2.14%
FULC | $6.86 -2.83% -2.92% 560K |

Health Technology

| -11.86% | O: -10.82% H: 17.27% C: 9.39%
therapeutics update results

---

BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-28 (Crawled : 20:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -2.88% | O: 3.37% H: 0.0% C: -0.19%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -7.9% | O: 0.58% H: 0.0% C: 0.0%
results

---

Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
Published: 2022-03-21 (Crawled : 01:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -0.79% | O: 4.8% H: 4.09% C: 4.09%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -6.91% | O: 0.96% H: 0.0% C: 0.0%
ZLAB | $14.08 -0.99% -0.99% 470K |

Health Technology

| -59.94% | O: 10.34% H: 0.0% C: 0.0%
zejula pos positive results positive results phase 3 primec

---

Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 12:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -6.0% | O: -1.77% H: 0.0% C: -3.55%
CGEM | $15.66 -13.29% -15.33% 1.2M |

| 27.84% | O: -2.53% H: 7.62% C: 7.29%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -5.06% | O: 0.6% H: 2.92% C: 2.21%
financial results report results

---

BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-30 (Crawled : 12:30) - biospace.com/
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 1.56% | O: 4.58% H: 0.0% C: -0.24%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -3.52% | O: 0.66% H: 0.0% C: 0.0%
financial results results

---

PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -3.9% | O: 1.14% H: 0.94% C: -1.98%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -44.57% | O: -1.58% H: 0.42% C: 0.24%
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -15.92% | O: 3.46% H: 0.7% C: -0.09%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -41.08% | O: 2.06% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -6.23% | O: 1.16% H: 0.75% C: -0.19%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 184.58% | O: -1.55% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -69.18% | O: 0.13% H: 3.09% C: 2.62%
ARVN | $34.78 1.43% 1.41% 940K |

Health Technology

| -60.04% | O: 1.4% H: 4.09% C: 4.07%
results

---

23andMe Reports FY2022 First Quarter Financial Results
Published: 2021-08-13 (Crawled : 12:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -3.66% | O: 0.8% H: 0.0% C: 0.0%
financial results results

---

Halozyme Reports Second Quarter 2021 Results
Published: 2021-08-09 (Crawled : 20:00) - halozyme.com
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -2.05% | O: 0.02% H: 0.38% C: 0.15%
HALO M | $38.64 2.2% 2.15% 1.3M |

Health Technology

| -4.45% | O: 14.02% H: 0.17% C: -10.56%
results report

---

Final Results
Published: 2021-07-05 (Crawled : 08:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
results

---

Lilly Delivers First-Quarter 2021 Financial Results, Adjusts 2021 Financial Guidance
Published: 2021-04-27 (Crawled : 12:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 5.21% | O: -0.03% H: 0.26% C: -0.11%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 287.94% | O: -1.72% H: 1.02% C: -0.97%
VIR | $7.96 0.0% 1.1M |

Health Technology

| -84.41% | O: 0.0% H: 0.16% C: -3.69%
RIGL | $1.07 1.91% 1.87% 810K |

Health Technology

| -72.31% | O: 1.54% H: 0.25% C: -3.28%
DTIL | $9.75 -9.05% -9.95% 170K |

Health Technology

| -1.42% | O: 0.4% H: 3.33% C: -1.11%
MRUS | $39.83 -1.58% -1.61% 800K |

Health Technology

| 70.42% | O: -0.64% H: 0.0% C: -2.8%
financial results results liver

---

CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
Published: 2021-04-15 (Crawled : 12:15) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 10.02% | O: 4.23% H: 1.59% C: 0.08%
CVAC | $2.44 0.0% 790K |

Health Technology

| -97.62% | O: 3.26% H: 2.34% C: -1.8%
financial results results

---

Liquidia Corporation Reports Full-Year 2020 Financial Results and Provides Corporate Update
Published: 2021-03-23 (Crawled : 12:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 8.4% | O: -1.15% H: 0.28% C: -0.72%
UTHR | $237.99 0.45% 0.45% 400K |

Health Technology

| 41.32% | O: -0.07% H: 0.7% C: -1.97%
LQDA M | $13.31 -3.62% -3.76% 830K |

Health Technology

| 390.41% | O: -2.21% H: 1.51% C: -3.77%
financial results results

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---